Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.25 USD | +0.59% | -3.41% | +92.73% |
Jun. 03 | Merus Says Target Tumors in Lung Cancer Patients Decrease in Size After MCLA-129 Treatment | MT |
Jun. 03 | Truist Securities Raises Price Target on Merus to $88 From $69, Maintains Buy Rating | MT |